The following specialists in the treatment of malignant mesothelioma:
DAVID C. RICE, MD: Chief, Division of Thoracic Surgery/Brigham and Women's Hospital, Boston, MA Chief, Department of Surgical Services/Dana-Farber Cancer Institute, Boston, MA Phone: (617) 732-6824 Dr. Sugarbaker believes in aggressive treatment of pleural mesothelioma. He is an advocate of tri-modal therapy; extrapleural pneumonectomy, chemotherapy and radiation.
DAVID J. SUGARBAKER, MD: Chief, Division of Thoracic Surgery/Brigham and Women's Hospital, Boston, MA Chief, Department of Surgical Services/Dana-Farber Cancer Institute, Boston, MA Phone: (617) 732-6824 Dr. Sugarbaker believes in aggressive treatment of pleural mesothelioma. He is a proponent of tri-modal therapy; extrapleural pneumonectomy, chemotherapy and radiation.
VALERIE W. RUSCH, FACS: Attending Thoracic Surgeon/Memorial-Sloan Kettering Cancer Center, New York, NY Phone: (212) 639-2806 Dr. Flores at present principal Investigator on a clinical trial of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation as well as involved in extrapleural pneumonectomy and high dose radiation.
PAUL H. SUGARBAKER, MD, FACS, FRCS Director, Surgical Oncology/Washington Cancer Institute, Washington, DC Phone: (202) 877-3908 Dr. Sugarbaker is a specialist in the treatment of peritoneal mesothelioma using a combination of surgery, chemotherapy and radiation.
BRIAN W. LOGGIE, MD Professor of Surgery, Creighton University Medical School; Chief, Division of Surgical Oncology; Director of Cancer Center/Creighton University Medical Center, Omaha, NE Phone: (402) 280-4100 Dr. Loggie specializes in the treatment of peritoneal mesothelioma and peritoneal carcinomatosis. His protocol, based on eligibility, involves surgical debulking in combination with intraperitoneal heated chemotherapy.
DAVID L. BARTLETT, MD Professor of Surgery, Chief, Division of Surgical Oncology/UPMC Cancer Pavilion, Pittsburgh, PA Phone: (412) 692-2852 Dr. Bartlett has particular expertise in the management of advanced, complex abdominal malignancies. He also has a research interest in treating advanced carcinomas in the peritoneal cavity, including peritoneal mesothelioma.
LARY A. ROBINSON, MD Director, Division of Cardiovascular and Thoracic Surgery Principal Thoracic Surgical Oncologist/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL Phone: (813) 972-8412.